Kyorin Pharmaceutical Co (TSE:4569) Marketable Securities : 円499 Mil (As of Sep. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Kyorin Pharmaceutical Co Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Kyorin Pharmaceutical Co's Marketable Securities for the quarter that ended in Sep. 2024 was 円499 Mil.

Kyorin Pharmaceutical Co's annual Marketable Securities increased from Mar. 2023 (円0 Mil) to Mar. 2024 (円99 Mil) and increased from Mar. 2024 (円99 Mil) to Mar. 2025 (円1,493 Mil).

Kyorin Pharmaceutical Co Marketable Securities Historical Data

The historical data trend for Kyorin Pharmaceutical Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kyorin Pharmaceutical Co Marketable Securities Chart

Kyorin Pharmaceutical Co Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Marketable Securities

Get a 7-Day Free Trial

3,399.00

500.00

99.00

1,493.00

Kyorin Pharmaceutical Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Mar25
Marketable Securities	Get a 7-Day Free Trial															-	99.00	-	499.00	1,493.00

Kyorin Pharmaceutical Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Kyorin Pharmaceutical Co (TSE:4569) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Kyorin Pharmaceutical Co Marketable Securities Related Terms

Thank you for viewing the detailed overview of Kyorin Pharmaceutical Co's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Kyorin Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kyorin Pharmaceutical Co Ltd (TSE:4569) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

KYRNF:USA

Address

6, Kanda Surugadai 4-chome, Chiyoda-ku, Tokyo, JPN, 101-8311

Website

https://www.kyorin-pharm.co.jp

Kyorin Pharmaceutical Co Ltd is engaged in manufacturing and sale of pharmaceutical products. The company manages its business in two reportable segments namely Pharmaceutical Business and the Consumer Healthcare (Skincare) Business. The Pharmaceutical business focuses on producing and selling ethical drugs, generic drugs and over-the-counter drugs. The Consumer Healthcare (Skincare) Business mainly sells and purchases skincare products. The company's products include Kipres, for treating bronchial asthma and allergic rhinitis; Mucodyne, a mucoregulant; Pentasa, for treating ulcerative colitis and Crohn's disease; and Uritos, for treating overactive bladder. Majority of the company's revenue comes from domestic sales.

Kyorin Pharmaceutical Co Headlines

No Headlines